Our group has recently demonstrated that Arg1 has a neuroprotective role in mouse models of both retinal ischemia/reperfusion injury and ischemic stroke, and further demonstrated the beneficial effects of Arg1 treatment in the form of intravitreal and intraperitoneal injections [18,19]. The gene discussed is ARG1; the disease is retinal ischemia.